Blueprint Medicines Corporation
Clinical trials sponsored by Blueprint Medicines Corporation, explained in plain language.
A precision medicine company developing targeted therapies for cancer and rare diseases.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New pill could tame stubborn hives that antihistamines Can't stop
Disease control OngoingThis study tests an experimental drug called BLU-808 for people with chronic hives (urticaria) that don't get better with standard antihistamines. The drug works by blocking a protein called KIT, which may help control the allergic reaction causing the hives. About 105 adults wil…
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug aims to ease symptoms of rare mast cell disease
Symptom relief OngoingThis phase 2 study tests whether avapritinib, a targeted drug taken as a tablet, can reduce symptoms in people with indolent systemic mastocytosis whose symptoms are not well controlled by standard care. About 251 participants will receive either avapritinib or a placebo, and all…
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC